Cargando…
Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
The SARS-CoV-2 non-structural protein 1 (Nsp1) contains an N-terminal domain and C-terminal helices connected by a short linker region. The C-terminal helices of Nsp1 (Nsp1-C-ter) from SARS-CoV-2 bind in the mRNA entry channel of the 40S ribosomal subunit and blocks mRNA entry, thereby shutting down...
Autores principales: | Afsar, Mohammad, Narayan, Rohan, Akhtar, Md Noor, Das, Deepakash, Rahil, Huma, Nagaraj, Santhosh Kambaiah, Eswarappa, Sandeep M, Tripathi, Shashank, Hussain, Tanweer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018067/ https://www.ncbi.nlm.nih.gov/pubmed/35323109 http://dx.doi.org/10.7554/eLife.74877 |
Ejemplares similares
-
Indian scorpions collected in Karnataka: maintenance in captivity, venom extraction and toxicity studies
por: Nagaraj, Santhosh Kambaiah, et al.
Publicado: (2015) -
Evidence for low-level translation in human erythrocytes
por: Kumar, Sangeetha Devi, et al.
Publicado: (2022) -
The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
por: Shen, Min, et al.
Publicado: (2023) -
Cellular Signaling Analysis shows antiviral, ribavirin-mediated ribosomal signaling modulation
por: Ding, Xianting, et al.
Publicado: (2019) -
Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment
por: Jung, Lindsey S, et al.
Publicado: (2020)